Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

Randomized clinical trials have shown mRNA-based vaccines to be 92–95% effective to prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of severe COVID-19 (requiring hospitalization) in elderly people. Each 1,422,461 vaccinated subject aged 75 or older was matched...

Descripción completa

Detalles Bibliográficos
Autores principales: Botton, Jérémie, Dray-Spira, Rosemary, Baricault, Bérangère, Drouin, Jérôme, Bertrand, Marion, Jabagi, Marie-Joëlle, Weill, Alain, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664658/
https://www.ncbi.nlm.nih.gov/pubmed/34924220
http://dx.doi.org/10.1016/j.vaccine.2021.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664658/
https://www.ncbi.nlm.nih.gov/pubmed/34924220
http://dx.doi.org/10.1016/j.vaccine.2021.12.009

Ejemplares similares